55 related articles for article (PubMed ID: 8471780)
1. Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens.
Niederwieser D; Grassegger A; Auböck J; Herold M; Nachbaur D; Rosenmayr A; Gächter A; Nussbaumer W; Gaggl S; Ritter M
Blood; 1993 Apr; 81(8):2200-8. PubMed ID: 8471780
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
Hahn T; McCarthy PL; Zhang MJ; Wang D; Arora M; Frangoul H; Gale RP; Hale GA; Horan J; Isola L; Maziarz RT; van Rood JJ; Gupta V; Halter J; Reddy V; Tiberghien P; Litzow M; Anasetti C; Pavletic S; Ringdén O
J Clin Oncol; 2008 Dec; 26(35):5728-34. PubMed ID: 18981462
[TBL] [Abstract][Full Text] [Related]
3. Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts; studies of normal polyclonal T cells and T lymphocyte clones derived early after allogenic bone marrow transplantation.
Bruserud O; Pawelec G
Cancer Immunol Immunother; 1996 Mar; 42(3):133-40. PubMed ID: 8640841
[TBL] [Abstract][Full Text] [Related]
4. T-cell receptor Valpha spectratype analysis of a CD4-mediated T-cell response against minor histocompatibility antigens involved in severe graft-versus-host disease.
DiRienzo CG; Murphy GF; Jones SC; Korngold R; Friedman TM
Biol Blood Marrow Transplant; 2006 Aug; 12(8):818-27. PubMed ID: 16864052
[TBL] [Abstract][Full Text] [Related]
5. Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation.
Beatty GL; Smith JS; Reshef R; Patel KP; Colligon TA; Vance BA; Frey NV; Johnson FB; Porter DL; Vonderheide RH
Clin Cancer Res; 2009 Aug; 15(15):4944-53. PubMed ID: 19602548
[TBL] [Abstract][Full Text] [Related]
6. Propagation of cytotoxic effectors from chronic myeloid leukemia patients and cloning of cytotoxic T cells.
Somasundaram R; Advani SH; Gangal SG
Cancer Immunol Immunother; 1988; 27(2):183-9. PubMed ID: 3262015
[TBL] [Abstract][Full Text] [Related]
7. Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor beta loci sequences.
Michalek J; Collins RH; Durrani HP; Vaclavkova P; Ruff LE; Douek DC; Vitetta ES
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1180-4. PubMed ID: 12531922
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects.
Melenhorst JJ; Leen AM; Bollard CM; Quigley MF; Price DA; Rooney CM; Brenner MK; Barrett AJ; Heslop HE
Blood; 2010 Nov; 116(22):4700-2. PubMed ID: 20709906
[TBL] [Abstract][Full Text] [Related]
9. Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens.
Fuchs KJ; van de Meent M; Honders MW; Khatri I; Kester MGD; Koster EAS; Koutsoumpli G; de Ru AH; van Bergen CAM; van Veelen PA; 't Hoen PAC; van Balen P; van den Akker EB; Veelken JH; Halkes CJM; Falkenburg JHF; Griffioen M
Blood; 2024 May; 143(18):1856-1872. PubMed ID: 38427583
[TBL] [Abstract][Full Text] [Related]
10. Deficient expression of class-I HLA in some cases of acute leukemia.
Elkins WL; Pickard A; Pierson GR
Cancer Immunol Immunother; 1984; 18(2):91-100. PubMed ID: 6239685
[TBL] [Abstract][Full Text] [Related]
11. Donor bone marrow-derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice.
Adams RC; Carter-Cusack D; Shaikh SN; Llanes GT; Johnston RL; Quaife-Ryan G; Boyle G; Koufariotis LT; Möller A; Blazar BR; Vukovic J; MacDonald KPA
Blood; 2022 Mar; 139(9):1389-1408. PubMed ID: 34570880
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic and noncytotoxic mechanisms involved in the in vitro anti-leukaemia effects of T cell clones established from a chronic myelogenous leukaemia patient during treatment in vivo with interferon alpha.
Pawelec G; Reutter M; Owsianowsky M; Rehbein A; Busch FW
Cancer Immunol Immunother; 1991; 33(1):54-60. PubMed ID: 1902397
[TBL] [Abstract][Full Text] [Related]
13. Development of a Minor Histocompatibility Antigen Vaccine Regimen in the Canine Model of Hematopoietic Cell Transplantation.
Rosinski SL; Stone B; Graves SS; Fuller DH; De Rosa SC; Spies GA; Mize GJ; Fuller JT; Storb R
Transplantation; 2015 Oct; 99(10):2083-94. PubMed ID: 25965411
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of the hematopoietic-restricted minor histocompatibility antigen LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysis.
Overes IM; Levenga TH; Vos JC; van Horssen-Zoetbrood A; van der Voort R; De Mulder PH; de Witte TM; Dolstra H
Cancer Immunol Immunother; 2009 Mar; 58(3):429-39. PubMed ID: 18719914
[TBL] [Abstract][Full Text] [Related]
15. Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells.
Molldrem JJ; Lee PP; Kant S; Wieder E; Jiang W; Lu S; Wang C; Davis MM
J Clin Invest; 2003 Mar; 111(5):639-47. PubMed ID: 12618518
[TBL] [Abstract][Full Text] [Related]
16. Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells.
Rimando JC; Chendamarai E; Rettig MP; Jayasinghe R; Christopher MJ; Ritchey JK; Christ S; Kim MY; Bonvini E; DiPersio JF
Blood; 2023 Apr; 141(14):1718-1723. PubMed ID: 36563336
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses.
Chan KL; Gomez J; Cardinez C; Kumari N; Sparbier CE; Lam EYN; Yeung MM; Garciaz S; Kuzich JA; Ong DM; Brown FC; Chan YC; Vassiliadis D; Wainwright EN; Motazedian A; Gillespie A; Fennell KA; Lai J; House IG; Macpherson L; Ang CS; Dawson SJ; Beavis PA; Wei AH; Burr ML; Dawson MA
Cancer Cell; 2022 Oct; 40(10):1190-1206.e9. PubMed ID: 36179686
[TBL] [Abstract][Full Text] [Related]
18. In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission.
Somasundaram R; Rao SG; Advani SH; Gangal SG
Cancer Immunol Immunother; 1988; 27(2):177-82. PubMed ID: 3262014
[TBL] [Abstract][Full Text] [Related]
19. T-Cell activation by t(9;22) acute lymphoblastic leukemia-derived dendritic-like cells is associated with increased tapasin expression.
Claus JA; Brady MT; Lee J; Donohue KA; Sait SN; Ferrone S; Wetzler M
Cancer Immunol Immunother; 2006 Feb; 55(2):160-5. PubMed ID: 16010586
[TBL] [Abstract][Full Text] [Related]
20. Universal cell donor lines: A review of the current research.
Simpson A; Hewitt AW; Fairfax KA
Stem Cell Reports; 2023 Nov; 18(11):2038-2046. PubMed ID: 37832541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
